Gene Therapy to Treat Batten Disease Video

Learn about the Gene therapy which is showing promise for the treatment of Batten disease, a rare and fatal neurological condition in this medical report.
Read the full transcript »

Susan Sharma: This is insidermedicine in 60. From New York, gene therapy is showing promise for the treatment of batten disease a rare and fatal neurological condition. Researches injected healthy genetic material derived in a viral vector into the brain of a patient with batten disease and noticed just slowing of the disease's progression. These results may be promising for those with battens and other neurologic conditions. From Ottawa, with the study showing that Trasylol also known as aprotinin raises the risk of death following heart surgery by 50%. Bayer has suspended further manufacturing and marketing, it's a compound. All the medication became widely available in 1993, suspensions regarding its increased risk started in 2006 following the publication of the paper and linking it to heart attacks, stroke and kidney failure. And finally from London in correspondence published in the Lancet it is argued that important part of the solution to elevating both the oil and food crisis is to get those who are obese more active and obese population with the BMI of 29 when compared to one with BMI of 24 and a half needs to consume 18% more calories. If over one billion people are obese this increment puts immense pressure on the food supply as well can be increase mass more fuels needed to transport those who are obese. For insidermedicine in 60, I'm doctor Susan Sharma.

Advertisement
Advertisement
Advertisement